The new head of the Office of Civil Defense (OCD) assumed command of the disaster response agency on Tuesday.

Undersecretary Harold Cabreros took his oath as OCD administrator before Defense Secretary Gilberto Teodoro Jr. in a ceremony at Camp Aguinaldo, Quezon City.
Cabreros replaced OCD officer-in-charge and concurrent deputy administrator for administration, Assistant Secretary Bernardo Rafaelito Alejandro IV.
Harold Cabreros takes post as new OCD chief
Alejandro was named OCD officer-in-charge in June after then-OCD chief Ariel Nepomuceno was appointed Bureau of Customs commissioner.
Teodoro expressed confidence in Cabreros’ leadership and capabilities to steer the country’s comprehensive civil defense and disaster resilience programs, in support of the National Disaster Risk Reduction and Management Council.
Cabreros previously served as director of the Rehabilitation and Recovery Management Service of the OCD.
Harold Cabreros takes post as new OCD chief, This news data comes from:http://gyglfs.com
A member of Philippine Military Academy Class of 1984, he joined the agency in 2017 shortly after his retirement from the military.
The OCD is the primary government agency mandated to implement and administer policies, strategies, and systems to reduce the country’s vulnerabilities and risks to hazards, as well as manage the consequences of disasters.
- 15 companies vie for 'Sustainability Champions' award
- May 12 poll results accurate, credible - OCTA Research
- Government work, classes on Tuesday suspended due to bad weather
- Pope Leo meets LGBTQ+ Catholic advocate and vows continuity with Pope Francis' legacy of welcome
- DoJ to begin preliminary investigation into missing cockfighting enthusiasts
- Filipino member of AHOF K-pop group says Manila concert a dream come true
- Some National Guard units in Washington are now carrying firearms in escalation of Trump deployment
- Philippines presses call for ceasefire in Gaza
- Wildfire tears through California gold rush town
- Trump plans a hefty tax on imported drugs, risking higher prices and shortages